A new executive order takes decisive steps to improve the safety and oversight of biological research, especially dangerous gain-of-function experiments. It halts U.S. funding for risky research conducted abroad in…
Learn MoreThis executive order aims to eliminate regulatory roadblocks that slow the domestic production of critical medicines. It directs multiple federal agencies—including the FDA, EPA, and Army Corps of Engineers—to streamline…
Learn MoreThis executive order establishes the National Center for Warrior Independence to provide housing, care, and support services for homeless veterans, starting with a major redevelopment of the West Los Angeles…
Learn MoreThis executive order aims to bring fairness to prescription drug pricing by ensuring Americans pay no more than patients in other developed nations. It directs federal agencies to push for…
Learn MoreThis executive order renews a comprehensive campaign to lower prescription drug prices by prioritizing patient access, transparency, and market competition. It directs federal agencies to reform Medicare drug negotiations, stabilize…
Learn MoreAs the healthcare landscape shifts, securing diverse funding is essential to sustain primary care research. This resource offers guidance on tapping into federal agencies, foundations, healthcare systems, and even private…
Learn MoreCelebrating five decades of service, the Administration for Native Americans reflects on its journey of supporting tribal self-determination through grants, partnerships, and culturally grounded initiatives. The report highlights landmark efforts…
Learn MoreThe FY 2025 Congressional Budget Justification for the Department of State and USAID outlines a $58.8 billion request to advance diplomacy, development, and national security efforts worldwide. Key priorities include…
Learn MoreAs more U.S. states adopt paid sick leave (PSL) mandates, new research reveals that these policies are helping parents spend more time caring for their children. Using nearly two decades…
Learn MoreThis study examines how Alaska schools are adopting trauma-engaged practices, finding that most are in the early stages of implementation despite growing awareness of childhood trauma’s impact on student well-being.…
Learn MoreIn a renewed push for healthcare transparency, the President has issued an Executive Order aimed at empowering patients with clear, accurate, and actionable pricing information. The directive builds on previous…
Learn MoreED boarding—where admitted patients wait in the ER for inpatient beds—isn’t just an inconvenience, it’s a public health crisis. The AHRQ Summit convened health leaders to tackle this systemic problem…
Learn MoreThe Inflation Reduction Act introduced a pricing policy that gives small-molecule drugs only 9 years of market exclusivity—four fewer than their large-molecule counterparts. While aiming to reduce costs, this distinction…
Learn MoreNot all pharmaceutical breakthroughs are brand-new molecules—some of the most impactful innovations are the ones that refine what already exists. Follow-on biopharma innovations enhance existing therapies by improving safety, tailoring…
Learn MoreDisasters are becoming deadlier, more frequent, and costlier—and the federal approach to helping communities recover is straining under the pressure. With over 600 open disaster declarations and billions in aid…
Learn More